Opinion: Big Pharma Sold Its Supply Chain in the 1980s. The Bill Is Still Coming Due
A biotech CEO in 2024 negotiates a cell-therapy manufacturing slot with a contract organisation booked eighteen months out. She doesn't own a single piece…
Writer
Hedley Rees, Managing Consultant, PharmaFlow Limited